KRFK is a TGF-β agonist peptide derived from thrombospondin-1 (TSP-1) that activates the TGF-β pathway. This compound enhances TGF-β-mediated signaling and its downstream effects, operating independently of TSP receptors, including CD47 and CD36. KRFK is ideally suited for research applications involving chronic ocular surface inflammatory disorders.
KRFK is a TGF-β agonist peptide derived from thrombospondin-1 (TSP-1) that activates the TGF-β pathway. This compound enhances TGF-β-mediated signaling and its downstream effects, operating independently of TSP receptors, including CD47 and CD36. KRFK is ideally suited for research applications involving chronic ocular surface inflammatory disorders.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula: